Company intelligence / Profile preview

Biologics International

Florence, Kentucky, United States

Ownership: Private
Employees: ~51
Development stage: Other

Overview

Biologics International is an active US-based biotech services company offering custom recombinant protein and antibody production services for clients worldwide. It operates commercially as a platform provider for custom biologics, supporting research, therapeutic, and diagnostic clients globally, with established experience in providing stable cell lines and a range of species capabilities for antibody production, including technologies such as protein expression, stable cell line creation, and multispecies antibody generation.

Modalities: Recombinant proteinAntibody
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Biologics International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biologics International.

Explore the full profile